Table 2.

MET uptake, rCBV values, and counts of histological cell markers, with statistical correlations between the various parameters for all four patients

Patient 1	MET	rCBV	IDH1	Ki67	CD34
ROI 1 (16)	1.58	1.10	1741.59	59.71	273.32
ROI 2 (7)	1.06	1.10	454.92	32.94	133.49
ROI 3 (6)	0.80	0.90	36.66	16.07	108.98
MET (29)	N/A	r = 0.06; p = 0.7384	r = 0.91; p < 0.0001*	r = 0.71; p = 0.0465*	r = 0.73; p < 0.0001*
rCBV (29)	r = 0.06; p = 0.7384	N/A	r = 0.06; p = 0.7481	r = 0.07; p = 0.8665	r = 0.23; p = 0.2309
Patient 2	MET	rCBV	IDH1	Ki67	CD34
ROI 1 (8)	2.43	1.56	3214.15	88.44	353.49
ROI 2 (4)	1.38	0.80	3278.65	95.81	343.79
ROI 3 (5)	0.88	1.14	343.44	162.04	409.31
MET (17)	N/A	r = 0.36; p = 0.1524	r = 0.51; p = 0.0345*	r = 0.15; p = 0.5604	r = 0.43; p = 0.3965
rCBV (17)	r = 0.36; p = 0.1524	N/A	r = 0.10; p = 0.6942	r = 0.24; p = 0.3531	r = 0.20; p = 0.7040
Patient 3	MET	rCBV	IDH1	Ki67	CD34
ROI 1 (14)	1.22	1.66	976.89	168.18	340.70
ROI 2 (5)	0.84	1.32	758.37	75.55	136.01
ROI 3 (4)	0.63	0.85	341.07	54.24	114.17
MET (23)	N/A	r = 0.28; p = 0.1912	r = 0.44; p = 0.0371*	r = 0.69; p = 0.0095*	r = 0.67; p = 0.0005*
rCBV (23)	r = 0.28; p = 0.1912	N/A	r = 0.10; p = 0.6343	r = 0.53; p = 0.0640	r = 0.35; p = 0.0977
Patient 4	MET	rCBV	IDH1	Ki67	CD34
ROI 1 (9)	2.79	2.02	68.73	183.14	371.61
ROI 2 (5)	1.43	1.63	3.13	178.33	215.74
ROI 3 (1)	0.85	2.35	0.22	180.89	637.20
MET (15)	N/A	r = 0.08; p = 0.7710	r = 0.85; p < 0.0001*	r = 0.25; p = 0.3688	r = 0.02; p = 0.9496
rCBV (15)	r = 0.08; p = 0.7710	N/A	r = 0.15; p = 0.5848	r = 0.16; p = 0.5585	r = 0.49; p = 0.0664